Summary • Euda Health Holdings Limited (NASDAQ: EUDA) shares dropped 8.8% in pre-market trading, priced at $1.75.• The company recently launched a stem cell therapy platform and opened a clinic in ...

Summary • Skye Bioscience, Inc. (SKYE) sees a 12% pre-market increase, now priced at $0.9530.• Multiple class action lawsuits have been filed against SKYE, focusing on alleged securities fraud.• ...

Summary • SeaStar Medical’s stock dropped 8.7% to $0.2148 after announcing a 1-for-10 reverse stock split.• The reverse split, effective January 5, 2026, aims to increase share price and attract ...

Summary • Iterum Therapeutics plc (ITRM) is down 6.1% in after-hours trading, currently at $0.3202. • The company recently secured a significant PBM agreement for its antibiotic ORLYNVAH™, but faced ...

Southern Copper Corporation (SCCO) received an “Underperform” rating from Daniel Sasson at Itau BBA. This downgrade, along with a price target set at $126—down from a prior consensus of ...

Bill Katz from TD Cowen assigned a “Hold” rating on shares of Janus Henderson Group plc (JHG), reflecting a cautious optimism in a landscape marked by fluctuating market conditions. With a price ...

Summary • Anebulo Pharmaceuticals shares dropped nearly 16.0% to $1.445 following the announcement of a cash tender offer.• The tender offer indicates a strategic shift towards going private, ...

Clearwater Analytics Holdings, Inc. (CWAN) recently garnered a Neutral rating from Patrick Moley of Piper Sandler, with a price target set at $27. This analysis comes amid a complex landscape of ...

Summary • Warner Bros. Discovery, Inc. has increased 1.3% to $29.12 amid an unsolicited tender offer from Paramount Skydance.• The company has recommended shareholders reject the $30 per share cash ...

Line” rating from Robert Ottenstein at Evercore ISI Group, signaling a cautious yet optimistic outlook for the beauty and personal care company. The rating, issued on December 23, 2025, highlights ...

Summary • Scienture Holdings, Inc. (SCNX) stocks surged 12.98% to $0.5891 following a commercial launch update of its naloxone product, REZENOPY®. • REZENOPY® targets a significant U.S. naloxone ...

Summary • Trinity Biotech plc (TRIB) experienced a 54.2% increase in intraday trading, reaching $1.3754 per share following announcements of financial agreements.• The agreements extend credit ...